| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $10.23B | $8.01B | $6.86B | $5.69B | $5.00B |
| Cost of Revenue | $6.51B | $5.08B | $4.46B | $4.08B | $3.48B |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $441.70M | $352.10M | $303.50M | $282.00M | $266.40M |
| SG&A | $1.62B | $1.37B | $1.31B | $1.18B | $1.11B |
| Operating Income | $1.83B | $1.37B | $872.20M | $223.40M | $259.90M |
| Interest Expense | $86.10M | $150.40M | $180.10M | $147.30M | $90.60M |
| Tax Expense | $409.10M | $269.60M | $73.50M | $90.40M | $46.60M |
| Net Income | $1.33B | $495.80M | $460.20M | $76.60M | $119.60M |
| EPS (basic) | 3.4900 | 1.3200 | 1.2100 | 0.2000 | 0.3400 |
| EPS (diluted) | 3.4100 | 1.2800 | 1.1900 | -0.0400 | 0.3300 |
| Shares (diluted) | $390.65M | $386.33M | $386.23M | $378.22M | $360.14M |